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Formation of functional heterologous complexes using subunits
from the picromycin, erythromycin and oleandomycin polyketide
synthases
Li Tang, Hong Fu and Robert McDaniel
Background: Recently developed tools for the genetic manipulation of modular
polyketide synthases (PKSs) have advanced the development of combinatorial
biosynthesis technologies for drug discovery. Although many of the current
techniques involve engineering individual domains or modules of the PKS, few
experiments have addressed the ability to combine entire protein subunits from
different modular PKSs to create hybrid polyketide pathways. We investigated
this possibility by in vivo assembly of heterologous PKS complexes using
natural and altered subunits from related macrolide PKSs.
Results: The pikAI and pikAII genes encoding subunits 1 and 2 (modules 1–4)
of the picromycin PKS (PikPKS) and the eryAIII gene encoding subunit 3
(modules 5–6) of the 6-deoxyerythronolide B synthase (DEBS) were cloned in
two compatible Streptomyces expression vectors. A strain of Streptomyces
lividans co-transformed with the two vectors produced the hybrid macrolactone
3-hydroxynarbonolide. Co-expression of the same pik genes with the gene for
subunit 3 of the oleandomycin PKS (OlePKS) was also successful. A series of
hybrid polyketide pathways was then constructed by combining PikPKS
subunits 1 and 2 with modified DEBS3 subunits containing engineered
domains in modules 5 or 6. We also report the effect of junction location in a
set of DEBS–PikPKS fusions.
Conclusions: We show that natural as well as engineered protein subunits
from heterologous modular PKSs can be functionally assembled to create
hybrid polyketide pathways. This work represents a new strategy that
complements earlier domain engineering approaches for combinatorial
biosynthesis in which complete modules or PKS protein subunits, in addition to
individual enzymatic domains, are used as building blocks for PKS engineering.
Introduction
Modular type I polyketide synthases (PKSs) catalyze the
biosynthesis of macrolides and other macrocyclic polyke-
tides, which have valuable medicinal properties. These
multienzyme assemblies are formed by large multifunc-
tional proteins that harbor a distinct active site for each
step of catalysis in polyketide biosynthesis [1]. The active
sites are arranged into repeated modules, with each
subunit of the PKS complex containing from one to many
(up to six have been reported) modules (Figure 1) [2].
The development of genetic engineering strategies that
allow the structures of polyketides to be manipulated in
ways beyond those accessible by conventional chemical
approaches has utilized this convenient genetic and struc-
tural organization [3,4]. The direct correspondence between
the catalytic domains present and the structure of the
resulting biosynthetic product allows the polyketide struc-
ture to be altered by modifying the domains or modules of
the PKS. This makes modular PKSs attractive targets for
generating combinatorial polyketide libraries, as well as
engineering analogs of compounds with demonstrated
therapeutic activities [5,6].
The erythromycin PKS, 6-deoxyerythronolide B synthase
(DEBS), from Saccharopolyspora erythraea has been the
most widely used system for the development of such
methods. Using DEBS, a number of experiments have
shown that modular PKSs are amenable to a variety of tar-
geted genetic modifications, such as inactivation, substitu-
tion or addition of domains or modules [2,7–20]. Recently,
a combinatorial library of over 50 novel polyketides was
prepared by direct domain engineering in DEBS [5]. Col-
lectively, these experiments indicate that modular PKSs
are fairly tolerant towards unnatural PKS substrates and
that engineered modules maintain most of their structural
integrity. But in a majority of the cases, protein engineer-
ing has resulted in reduced in vivo productivity. An alter-
native strategy for combinatorial biosynthesis is to
assemble complete modules or protein subunits from
heterologous sources. This approach would help alleviate
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problems associated with structural imperfections that
may be created by the engineered domains in mutant
PKSs, including those reported in a previous study [5].
Favorable results obtained from recent functional module
replacement experiments suggest that individual or
groups of modules could also serve as functional units of
manipulation for the construction of hybrid biosynthetic
pathways [6,20]. Because many modules and subunits
from different PKS systems are now available for genetic
engineering, it is possible to examine their applicability
towards combinatorial biosynthesis.
The oleandomycin PKS (OlePKS) from Streptomyces
antibioticus and the picromycin PKS (PikPKS) from Strep-
tomyces venezuelae are closely related to DEBS and have
been completely sequenced ([21,22]; R.M., unpublished
observations). The OlePKS produces a polyketide product,
8,8a-deoxyoleandolide (2), which differs from the product
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Figure 1
Modular arrangement of the related PKSs that produce
(a) 6-deoxyerythronolide B (DEBS), (b) 8,8a-deoxyoleandolide
(OlePKS), and (c) narbonolide (PikPKS). Each PKS consists of six
modules, each of which catalyzes a round of condensation and
subsequent β-keto modification on the growing polyketide chain. The
colored modules highlight the differences in activities between each
PKS system and the polyketide produced ([23,24]; R.M., unpublished
observations). KS, ketosynthase; AT, acyltransferase; ACP, acyl carrier
protein; KR, ketoreductase; DH, dehydratase; ER, enoylreductase; TE,
thioesterase; KSQ, putative decarboxylation domain [32,33].
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of DEBS, 6-dEB (1), by only one carbon length in the
priming unit. The product of the full-length PikPKS, nar-
bonolide (3), differs from 6-dEB by a double bond at
C-10,11, the lack of a methyl at C-10, and a ketone at C-3,
all of which correspond to different activities or specifici-
ties of the active sites of modules 2 and 6, respectively.
(The PikPKS also produces the 12-membered macrolac-
tone, 10-deoxymethynolide, which results from premature
cyclization of the module 5 intermediate [22,23].) We
recently engineered a plasmid-based system for func-
tional expression of PikPKS in the heterologous host
Streptomyces lividans, which parallels the earlier described
heterologous expression system used for DEBS [23,24].
Along with cloned subunits from OlePKS, these expres-
sion systems provide a convenient means for construction
of heterologous PKS complexes in vivo, in which com-
plete modules or larger protein units are manipulated.
The compounds produced by all three PKSs are similar in
size and functionalization and therefore comprise an ideal
system to test whether polyketide intermediates can be
passed between heterologous protein subunits while min-
imizing specificity barriers resulting from non-natural
biosynthetic intermediates.
Here we report the successful construction of several het-
erologous PKS complexes in vivo generated by whole
subunit complementation or intermodular fusions with
these three modular PKS systems. The levels of polyke-
tide production in bacteria containing these complexes
were comparable to those obtained in the bacterial host
containing only cognate subunits, and indicate productive
association and transfer of biosynthetic intermediates
between the heterologous PKS components. We further
extend this application towards the development of com-
binatorial biosynthesis strategies by drawing from our
existing repertoire of genetically modified DEBS subunits
containing substituted domains from the rapamycin PKS
(RAPS), which are capable of generating a diversity of bio-
chemical features. The latter hybrid PKSs, containing het-
erologous PKS subunits as well as specific catalytic
domain modifications, serve to illustrate the flexibility in
engineering modular PKSs at many structural levels,
including whole subunits, modules, catalytic domains, and
various combinations.
Results and discussion
Hybrid PKS complexes with natural heterologous subunits
There are currently at least six modular PKSs belonging
to the class of 12-, 14- and 16-membered macrolide
antibiotics that have been sequenced at the DNA level.
The compounds produced by these PKSs (erythromycin,
picromycin/methymycin, oleandomycin, tylosin, nid-
damycin and mycinamicin) are structurally similar, but
each contains one or more differences when compared to
any other. One can therefore imagine designing ‘hybrid’
compounds incorporating the unique features from two or
more pathways. Any structural permutation could, in
theory, be produced by engineering the domains of each
PKS scaffold as was done to construct macrolide analogs
with DEBS. However, because the biosynthetic interme-
diates are similar between these PKSs, it is possible that
modules and subunits from the different PKSs could
functionally complement one another if they communi-
cated productively.
We examined the feasibility of modular PKS subunit com-
plementation by replacing PikAIII and PikAIV, the third
and fourth subunits of the PikPKS, encoding modules 5
and 6, with DEBS3 and OleA3, each encoding modules 5
and 6 of their respective PKSs (Figure 2). The amino-acid
identities between the pairs of subunits (considering
PikAIII and PikAIV together as one subunit) are 42% for
PikAIII/AIV:DEBS3 and also for PikAIII/AIV:OleA3. The
DEBS3 and OleA3 subunits differ from PikAIII/AIV by
the presence of a ketoreductase (KR) in module 6.
Because there is only 46% identity between DEBS3 and
OleA3, the subunits contain significant structural differ-
ences even though they are functionally equivalent. Based
on the collective body of modular PKS engineering exper-
iments, we expected that the DEBS3 and OleA3 subunits
would process the unnatural intermediate generated by
the PikPKS subunits. Whether the heterologous subunits
would possess sufficient homology to associate, if
required, or communicate properly had not been demon-
strated, however.
We utilized the same bivector system developed for sepa-
rate expression of DEBS subunits in S. lividans [25] to co-
express PKS subunits from PikPKS with DEBS and
OlePKS subunits. The pikAI and pikAII genes were placed
on a single plasmid (pKOS039-83), whereas eryAIII
(pKOS010-153) and oleAIII (labeled oleORFB in [21];
pKOS039-133) were each placed on separate vectors com-
patible with pKOS039-83 (see Table 1). Expression of the
genes is driven by the same promoter element, actIp, and
transcriptional activator, actII-ORF4, in all three plasmids.
Plasmid pKOS039-83 contains the replicating Streptomyces
origin from SCP2*, whereas plasmids pKOS010-153 and
pKOS039-133 contain the φC31-int-attP loci for chromoso-
mal integration [26]. Co-transformation of S. lividans
K4-114 by pKOS039-83 and pKOS010-153 or pKOS039-133
using appropriate antibiotic selection resulted in strains
capable of producing ~10 mg/l of the predicted hybrid
macrolactone, 3-hydroxy-narbonolide (4) (referred to as
10-desmethyl-10,11-anhydro-6dEB in previous literature
[5]; Figure 2) as determined using liquid chromatography/
mass spectrometry (LC/MS) and nuclear magnetic reso-
nance (NMR) spectroscopy. The amount of 4 produced
was similar to levels of narbonolide (3) produced when the
full set of PikPKS subunits was used [23]. It appears, there-
fore, that both the DEBS3 and OleA3 subunits fully com-
plement the PikAIII and PikAIV subunits. For comparison,
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the amount of 4 generated previously by replacement
of the acetyltransferase (AT) and ketoreductase (KR)
domains in module 2 of DEBS with RAPS cassettes was
below 0.1 mg/l [5]. By employing naturally occurring sub-
units from different macrolide PKSs, we were able to effect
a >100-fold improvement in yield of this compound.
Hybrid PKS complexes with modified heterologous subunits
The construction of modular PKS subunits on separate
expression vector systems holds certain advantages for
generating combinatorial libraries. Once a set of subunits
encoding different activities has been made, they may be
rapidly combined via serial or co-transformation of a suit-
able host. This was recently accomplished with a set of
modified DEBS subunits — containing domain deletions
or substitutions with domains from RAPS — using three
different expression vectors [27]. Because we had estab-
lished that the DEBS3 subunit functions well with the
PikAI and PikAII subunits, we decided to investigate
whether the existing set of modified DEBS3 subunits
could be used to propagate a series of narbonolide analogs.
Because the expression plasmids encoding the modified
DEBS3 were already available [27], it was convenient to
now combine them with the above plasmid, pKOS039-83,
in S. lividans using routine plasmid transformation.
Five DEBS3 subunits were selected, each containing a
deleted or substituted domain in module 5 or 6 (Figure 3).
These included a deletion of KR5 (pKOS025-1832), sub-
stitution of KR5 with rapDH/KR4 (pKOS025-1833), sub-
stitution of KR5 with rapDH/ER/KR1 (pKOS025-1834),
substitution of KR6 with rapDH/KR4 (pKOS025-1841),
and substitution of AT6 with rapAT2 (pKOS025-1842).
Each of these is contained on the same integrating expres-
sion vector as the wild-type DEBS3 protein (pKOS010-153).
All of the combinations produced at least one polyketide
product as determined by LC/MS analysis (Figure 3). In
the case of the two substitutions in module 6 and the KR5
deletion, the expected polyketides, 2-desmethyl-3-
hydroxynarbonolide (5), 3-deoxy-2,3-anhydronarbonolide
(6) and 5-deoxy-5-oxo-3-hydroxynarbonolide (7) were the
major products. For the two domain substitutions in
module 5, however, the expected compounds, 4,5-anhy-
dronarbonolide (8) and 5-deoxynarbonolide (9), were
detected in only trace amounts. Instead, the major com-
pound in each case, 5-deoxy-5-oxo-3-hydroxynarbonolide
(7), was formed presumably because the intermediate can
efficiently bypass the incorporated RAPS domain. This
was also observed when these mutations were introduced
into module 5 of the complete DEBS system [5,27], sug-
gesting that these RAPS domains do not operate optimally
when inserted into module 5 of DEBS.
In the above experiments, a combination of subunit com-
plementation and catalytic domain engineering was used to
engineer the hybrid PKSs. Four of the five constructs were
prepared using DNA derived from three different PKS
gene clusters. This illustrates the remarkable range of flex-
ibility that PKSs possess towards combinatorial engineer-
ing. Although many different permutations of subunits,
modules and domains could be pieced together to generate
a particular compound, clearly some combinations will
result in more productive enzyme complexes. For
example, in the previous DEBS library work, relatively few
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Figure 2
Polyketides produced by complementation with heterologous PKS subunits from PikPKS (purple), DEBS (red), and OlePKS (orange).
cm7204.qxd  03/03/2000  08:38  Page 80
macrolactones containing a 10-nor-10,11-anhydro moiety
were generated because the domain modification in module
2 of DEBS (AT2→rapAT2, KR2→rapDH/KR4) produced
only small amounts of 10-nor-10,11-anhydro-6-dEB [5]. We
have extended the number of novel macrolactones with this
functional arrangement by utilizing the naturally occurring
set of activities found in the PikPKS modules.
Hybrid pathways by intramodular fusions
The macrolides generated by the initial subunit comple-
mentation experiments above contain structural features
unique to the early steps of narbonolide biosynthesis (no
methyl at C-10, double bond at C-10,11) and the latter
steps of 6-dEB biosynthesis (hydroxyl at C-3). Conversely,
macrolactones with a methyl at C-10, hydroxyl at C-11 and
a ketone at C-3 (i.e. 3-keto-6-dEB) would result from the
early steps 6-dEB biosynthesis and latter steps of narbono-
lide biosynthesis. This compound has been produced pre-
viously by two different genetically engineered PKSs — a
deletion of the KR domain in DEBS [5], and a fusion of
the pikACP6 + TE to eryAT6 [23]. Recent success with
functional module substitutions prompted us to test how
PKSs engineered with complete module substitutions
would compare with the other engineered mutant PKSs
producing the same molecule.
The first attempt, in which module 6 of DEBS was
replaced by module 6 of PikPKS (pKOS039-76, Figure 4),
failed to produce any detectable polyketide. In this
fusion, the conserved BsaBI site at the start of DEBS KS6
was chosen for the junction site. The use of this con-
served site led to highly productive intermodule fusions
in a previous study by Gokhale et al. [20]. This hybrid
PKS also maintained the DEBS M5-6 intermodular linker
postulated to play a critical role in intermodular chain
transfer and it is therefore unclear why no products were
observed in this case.
Successful fusions between DEBS modules using junc-
tions within modules (intramodular) rather than between
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Figure 3
Combinatorial library production by complementation with genetically engineered PKS subunits from PikPKS (purple), DEBS (red) and domains
from RAPS (green).
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modules (intermodular) have also been described previ-
ously [28]. It seemed reasonable that modules from het-
erologous PKSs could also be connected in a similar
fashion. Two intramodular fusions were made between
modules 5 of DEBS and PikPKS to create hybrid modules
comprised of eryKS5 and AT5 domains, and pikKR5 and
ACP5 domains (Figure 4). The PKS encoded by plasmid
pKOS039-56 conserves the separate subunit architecture
of the PikPKS, whereas plasmid pKOS039-89 encodes a
PKS in which modules 5 and 6 are covalently linked.
S. lividans K4-114 transformed with plasmid pKOS039-56
produced ~3 mg/l of the expected macrolactone,
3,6-dideoxy-3-oxo-erythronolide B (10), verified by compar-
ing chromatography profiles, mass fragmentation and 1H
NMR spectrum to an authentic sample [5]. The strain with
plasmid pKOS039-89 also produced 10, although yields
were ~5–7-fold lower than those of the strain with plasmid
pKOS039-56. It appears, therefore, that the engineered
intermodular linker had an adverse affect on module assem-
bly. The linker in this PKS was created by ligating two nat-
urally occurring BspEI sites, resulting in the deletion of
nine amino acids from the carboxyl terminus of module 5
and the first 22 amino acids of the amino terminus of
module 6. This ‘unnatural’ linker might have disrupted
proper folding or association between modules 5 and 6.
The difficulties encountered with the pKOS039-76 and
pKOS039-89 constructs point towards the need to better
understand the role of intermodular and interpolypeptide
regions in the communication of PKS modules and sub-
units. However, the success of construct pKOS039-89
suggests that problems encountered with module fusions
might be circumvented by constructing fusion junctions
between the more highly conserved domains of modules,
thereby preserving the natural intermodular or inter-
polypeptide linkers. A similar conclusion was reached in
earlier work [28] and more recently by Ranganathan et al.
[6], who produced a number of bimodular and trimodular
hybrid PKSs with fusion junctions within modules.
Together, the results reported here and elsewhere illus-
trate that a diversity of PKS engineering strategies from
domain and module substitutions to subunit complemen-
tation and PKS fusions can be used for optimizing the
production levels of unnatural polyketides.
Significance
Modular polyketide synthases (PKSs) that produce
structurally similar compounds contain relatively minor
differences in their genetic programming. Because the
intermediates generated by the PKSs resemble each
other, there is a high probability that the modules of one
PKS will recognize and efficiently process the struc-
turally related intermediates from another PKS. We
demonstrate an approach to novel polyketide synthesis
by complementation of subunits from related modular
PKS systems. The advantage to this method is the struc-
tural conservation of naturally optimized protein sub-
units. We obtained high yields of ‘unnatural’ macrolide
compounds when compared to previous genetic con-
struction, which required engineering of individual
domains within a module. This indicates that there can
be good communication between noncovalent heterolo-
gous PKS modules. We also show that fusion junctions
within modules can be useful for conserving potential
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Figure 4
Engineered PKS fusions between DEBS (red) and PikPKS (purple). NP, no product.
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critical intermodular linker regions for constructing
hybrid pathways.
These techniques serve two useful functions for generat-
ing potential therapeutic compounds. First, the ability to
produce high yields of molecules that were produced at
lower levels by other engineering methods increases the
size of libraries made by combinatorial biosynthesis
methods. This was shown by coupling the subunit com-
plementation strategy with individual domain engineer-
ing to produce polyketide structures that were not
accessible in previous library constructions. Second, it
provides potential routes to high titers of hybrid com-
pounds from structurally related families of polyketides,
for example the 14- and 16-membered macrolide antibi-
otics (erythromycin, picromycin and tylosin), the
polyketide immunosupressant family (FK506, FK520
and rapamycin), or the ansamycin-containing
macrolides (rifamycin, geldanomycin and ansamitocin).
Materials and methods
Bacterial strains and media
S. lividans K4-114 [29] was the host used for expression of PKSs
and production of polyketides. S. lividans transformants were
selected on R2YE agar plates [30] using a 1 ml overlay of appropriate
antibiotic, thiostrepton (1 mg/ml) or apramycin (2 mg/ml). S. lividans
strains were grown in liquid R2YE (+ 50 mg/l thiostrepton) for produc-
tion and analysis of polyketides. Escherichia coli XL1-Blue was used
for DNA manipulation.
DNA manipulation
Transformation of S. lividans with plasmids was performed using the stan-
dard protoplast procedure [30]. For strains containing two expression
plasmids, plasmids were introduced serially by transformation. Routine
cloning was performed in Litmus28 (New England Biolabs) using stan-
dard procedures [31]. PCR was performed with Pfu polymerase (Strata-
gene) under conditions recommended by the manufacturer.
Construction of plasmids containing separate PKS subunits
Plasmid pKOS039-83, containing the pikAI and pikAII genes, is a
derivative of plasmid pKOS039-86 [23] in which the pikAIII and pikAIV
genes have been removed. It was constructed by first cloning a
15.68 kb Bgl II–Pst I fragment containing the pikAII gene and part of
the pikAI gene into the corresponding sites of Litmus28. The fragment
was then excised using Bgl II and Xba I and used to replace the
24.49 kb Bgl II–XbaI fragment in pKOS039-86 to generate
pKOS039-83. Plasmid pKOS010-153 containing the eryAIII gene has
been described previously [25]. Plasmid pKOS039-133 is a derivative
of pKOS010-153 in which the NdeI–XbaI fragment containing the
eryAIII gene has been replaced by the oleAIII gene (identified as
ORFB in [21]) from plasmid pKOS039-132. Plasmid pKOS039-132
was constructed by excising the 10.8 kb AscI–Pst I fragment of the
oleAIII gene from cosmid pKOS055–1 (S. Shah, unpublished observa-
tions) and ligating with EcoRI–Pst I-digested Litmus28 and a DNA
duplex linker created from the following two oligonucleotides:
5′-AATTCATATGGCTGAGGCGGAGAAGCTGCGCGAATACCTGT-
GG-3′; 5′-CGCGCCACAGGTATTCGCGCAGCTTCTCCGCCTCA-
GCCATATG-3′. The linker served to reconstruct the 5′ end of the oleAIII
gene from the start codon to the AscI site and introduce an NdeI site (in
italics) at the start codon. Plasmids pKOS025-1832, pKOS025-1833,
pKOS025-1834, pKOS025-1841 and pKOS025-1842, which contain
the engineered eryAIII genes, have been described previously [27]. The
plasmids used in this study are summarized in Table 1.
Construction of DEBS–PikPKS fusion plasmids
Plasmid pKOS039-56 contains a fusion between eryAT5 and pikKR5 at
the previously engineered Pst I site [5] immediately downstream of
eryAT5. The pik fragment containing the pikKR5-ACP and pikAIV was
subcloned as a Pst I–EcoRI fragment and placed into pKAO127′kan′ [29]
through a series of PCR and subcloning steps, resulting in the following
DNA sequence at the fusion junction (Pst I site in italics): 5′-AGCG-
GTACTGGCTGCAGAGCTCCGCGCC-3′. Plasmid pKOS039-89 is
identical to pKOS039-56 except the 198 nt BspEI fragment between the
end of pikACP5 and beginning of pikKS6 was deleted. Because the two
sites are in-frame, this creates a single open reading frame in which
modules 5 and 6 are translationally joined. Plasmid pKOS039-76 con-
tains a fusion between the beginning of eryKS6 and pikKS6 located at
the naturally occurring BsaBI restriction site in eryKS6. The pik was sub-
cloned as a BsaBI/EcoRI fragment and placed into pKAO127′kan′ via a
series of PCR and subcloning steps, resulting in the following DNA
sequence at the fusion junction (BsaBI site in italics) GGTGAGCC-
GATCGCGATCGTCGGCATGAG.
Analysis of polyketide products
S. lividans strains containing expression plasmids were grown in
2.5 ml liquid R2YE medium for 4 days at 30°C. Identification of polyke-
tides in the supernatants was performed by LC/MS as described previ-
ously [27]. Quantity of polyketide production was determined by
evaporative light scattering detection (ELSD). A previously character-
ized sample of 3,6-dideoxy-3-oxo-erythronolide B [5] was used to
confirm the structure of 10. Structural verification of 3-hydroxy-nar-
bonolide (4) is described below.
Purification and characterization of 3-hydroxy-narbonolide (4)
Seed cultures (30 ml each of liquid R2YE medium) of S. lividans
K4-114/pKOS039-83/pKOS039-133 were grown in eight flasks
(250 ml) for 3 days at 30°C. Each seed culture was used to inoculate a
2 l flask containing 400 ml of liquid R2YE medium and grown for an
additional 7 days. After centrifugation, the supernatants were combined
and extracted with ethyl acetate (3 × 3 l). The solvent phase was dried
over anhydrous MgSO4 and the ethyl acetate evaporated. Partial purifi-
cation was performed by silica gel chromatography (2 × 20 cm column,
ethyl acetate:hexane = 1:2). Fractions containing 3-hydroxy narbono-
lide (4) were identified by LC/MS and pooled. Final purification was
performed by HPLC using a C-18 reverse phase column (1 × 15 cm
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Table 1
Description of PKS expression plasmids used.
Plasmid PKS gene encoded Reference
pKOS039-83 pikAI and pikAII This study
pKOS010-153 eryAIII [25]
pKOS039-133 oleAIII This study
pKOS025-1832 eryAIII, ∆KR5 [27]
pKOS025-1833 eryAIII, eryKR5→rapDH/KR4 [27]
pKOS025-1834 eryAIII, eryKR5→rapDH/ER/KR [27]
pKOS025-1841 eryAIII, eryKR6→rapDH/KR4 [27]
pKOS025-1842 eryAIII, eryAT6→rapAT2 [27]
pKOS039-76 eryAI, eryAII, eryAIII/pikAIV This study
fusion at the conserved
BsaBI site at eryKS6
pKOS039-56 eryAI, eryAII, eryAIII/pikAIII This study
fusion between eryAT5
and pikKR5, pikAIV
pKOS010-89 Same as pKOS039-56 with This study
fusion between end of eryAIII/pikAIII
and start of pikAIV
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column, 15–80% acetonitrile/water gradient over 45 min) to obtain
5 mg of pure 4. The structure of 3-hydroxy narbonolide was confirmed
by 1H and 13C NMR spectroscopy and HRMS. Assignment of chemical
shifts was facilitated by HMQC–TOCSY experiments. 1H NMR
(400 MHz, CDCl3), δ (ppm), 6.97 (dd, 1H, J1 = 4.68 Hz, J2 = 16.24 Hz,
H-11), 6.11 (dd, 1H, J1 = 1.88 Hz, J2 = 16.20 Hz, H-10), 5.18 (m, 1H,
H-13), 3.67 (dd, 1H, J1 = 1.60 Hz, J2 = 8.92 Hz), H-3), 3.52 (broad,
1H, H-5), 2.86(m, 1H, H-8), 2.64 (m, 1H, H-12), 2.57 (dq, 1H, H-2),
1.58-1.86 (m, 5H, H-6, H-7, H-12), 1.43 (m, 1H, H-4), 1.25 (d, 3H,
J = 6.8 Hz, 2Me), 1.121 (d, 3H, J = 8 Hz, 12Me), 1.119 (d, J = 6.8 Hz
8Me), 1.01 (d, 3H, J = 6.9 Hz, 4Me), 0.95 (d, 3H, J = 6.8 Hz, 6Me),
0.94 (t, 3H, J = 7.2 Hz, 14Me). 13C NMR (400 MHz, CDCl3), δ (ppm);
204 (C-9), 176.1 (C-1), 150.1 (C-10), 126.7 (C-11), 77.2 (C-5), 76.3
(C-13), 75.2 (C-3), 44.1 (C-2), 42.0 (C-8), 50.6 (C-4), 39.0 (C-12),
35.7 (C-6), 35.4 (C-7), 19.3 (6Me), 17.9 (8Me), 14.9 (2Me), 10.4
(4Me), 10.3 (12 Me), 7.9 (15 Me). HRMS (FAB) calc’d for C20H34O5
[M + H]+ 355.248450; found 355.249010.
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